Located along the Temple-Austin biotechnology corridor, Emergent Biotechnologies was establish to address the commercial development of t several drugs having shown promise in the treatment of preeclampsia and ovarian cancer. The assembled team of scientists having professional backgrounds in the arenas of Medicinal Chemistry and Drug Development, Synthetic Organic and Medicinal Chemistry, Biochemistry, Molecular & Cellular Biology, Preclinical Drug Development, and Higher Education experience.
